Hearing on “Opportunities to Improve the 340B Drug Pricing Program,” Subcommittee on Health (July 11, 2018)

Livestream

Key Documents

Memorandum from Ranking Member Pallone to the Subcommittee on Health

Opening Statement of Ranking Member Pallone as prepared for delivery

Opening Statement of Subcommittee Ranking Member Green as prepared for delivery

Preliminary Transcript

Legislation

H.R. 2889, Closing Loopholes for Orphan Drugs Act, To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title. 

H.R. 4392, To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation.

H.R. 4710, 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE) Act, To amend the Public Health Service Act to establish a moratorium on the registration of certain new 340B hospitals and associated sites, and for other purposes. 

H.R. 5598, 340B Optimization Act, To amend the Public Health Service Act to require certain disproportionate share hospital covered entities under the 340B drug discount program to submit to the Secretary of Health and Human Services reports on low-income utilization rates of outpatient hospital services furnished by such entities. 

H.R. 6071, Stretching Entity Resources for Vulnerable (SERV) Communities Act, To amend the Public Health Service Act to clarify the intent of the 340B program and provide for enhanced 340B program integrity, and for other purposes. 

H.R. 6240, To amend the Public Health Service Act to provide for certain user fees under the 340B drug discount program.

H.R. 6273, To amend the Public Health Service Act to ensure appropriate care by certain 340B covered entities for victims of sexual assault, and for other purposes.

H.R. __, Protecting Safety-Net 340B Hospitals Act, To amend the Public Health Service Act to raise the minimum disproportionate share adjustment percentage required of certain hospitals as a condition of qualifying for the 340B drug discount program, and for other purposes.  

H.R. __, Bettering Operations and Oversight through Senate-process Transparency (BOOST) in 340B Act, To amend the Public Health Service Act to provide for an Administrator for the 340B Drug Discount Program, and for other purposes. 

H.R. __, To amend the Public Health Service Act to define the term patient for purposes of the 340B drug discount program. 

H.R. __, To require the Secretary of Health and Human Services to implement the Government Accountability Office recommendations.

H.R. __, To amend the Public Health Service Act to require under the 340B drug discount program reports by covered entities.

H.R. __, To amend the Public Health Service Act to require the Secretary of Health and Human Services to conduct audits. 

H.R. __, To amend the Public Health Service Act to require certain covered entities under the 340B drug discount program.

H.R. __, To amend the Public Health Service Act to allow the Secretary of Health and Human Services to prescribe regulation.

Witnesses

Panel I:

Debra A. Draper, PhD, MSHA
Director, Health Care
Government Accountability Office

Testimony 

Panel II:

Charles E. Daniels, BS Pharm, PhD
Pharmacist-In-Chief and Associate Dean
University of California, San Diego

Testimony

Frederick Cerise, MD, MPH
President and Chief Executive Officer
Parkland Health and Hospital System

Testimony

Debra Patt, MD, MPH, MBA
Vice President of Public Policy and Academic Affairs
Texas Oncology

Testimony